Xenetic Biosciences, Inc. Common Stock (NASDAQ: XBIO) last traded at $3.59, up 5.90% on the session. The quote above updates while this page is open; the figures below are drawn from Xenetic Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Xenetic Biosciences, Inc. Common Stock trades on NASDAQ under the ticker XBIO. Its market capitalisation is $8.41 million.
Valuation measures for Xenetic Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.41M |
|---|---|
| Price / sales | 2.58 |
| Price / book | 1.39 |
| Beta | 1.88 |
Trailing-twelve-month figures tagged in Xenetic Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.26M |
|---|---|
| Net income (TTM) | -$2.48M |
| EPS (TTM) | -$1.15 |
| Operating margin | -81.01% |
| Return on equity | -40.76% |
Range and volume for XBIO over the past 52 weeks.
| 52-week high | $13.93 |
|---|---|
| 52-week low | $1.90 |
| Volume | 83.5K |
| Average volume | 34.5K |
| Previous close | $3.39 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.